"Two patients with neuromyelitis optica spectrum disorder (NMOSD) have been in remission for over 15 years following stem-cell transplants. This is the first reported use of allogeneic stem-cell therapy for this condition. The treatment involves replacing the immune system to stop the production of harmful antibodies."